Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic inositol phosphate derivative belonging to the class of organic compounds known as inositol phosphates. It features a cyclohexane ring with multiple hydroxy and phosphate groups and an additional phosphorylated glycerol moiety. Inositol phosphates are important signaling molecules in eukaryotic cells and play roles in cellular processes such as signal transduction and membrane trafficking. The specific biological activity or mechanism of action for this particular derivative has not been established; it is classified as an experimental small molecule[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)].